1 / 8

NCATS Update

NCATS Update. Mary Purucker, MD, PhD NCATS CC-CHOC Coordinator CC-CHOC Quarterly Webinar 30 July 2012. New CTSA FOA. RFA-TR-006 for Institutional Clinical and Translational Science Awards (CTSA ) released July 6, 2012, http:// grants.nih.gov/grants/guide/rfa-files/RFA-TR-12-006.html

tekli
Télécharger la présentation

NCATS Update

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NCATS Update Mary Purucker, MD, PhD NCATS CC-CHOC Coordinator CC-CHOC Quarterly Webinar 30July 2012

  2. New CTSA FOA • RFA-TR-006 for Institutional Clinical and Translational Science Awards (CTSA) released July 6, 2012, http://grants.nih.gov/grants/guide/rfa-files/RFA-TR-12-006.html • Technical Assistance Webinar held July 23, 2012 • Slides & recording will be posted on NCATS website • Key CTSA FOA submission dates: • Letter of Intent Due: December 10, 2012 • Application Due: January 8, 2013 • NIH Peer Review: February/March 2013 • NCATS Advisory Council Review: May 2013 • Earliest Award Start: July 1, 2013 • Sendinquiries to CTSAFOAQuestions@mail.nih.gov. 2

  3. Salient Features: New CTSA FOA • Compared to Prior CTSA Funding Announcements: • New application required for all—no Type 2s/renewals • Emphasizes a limited number of cores with focus on strength of CTSA • New budget formula: 3% of total NIH funding for each institutional partner • Three major sections that align with the key CTSA components: • Leadership Section: Integrated Home Leadership & Governance • Resources and Services: To support the full range of translational research • Research Education, Training, and Career Development • Explicit support for child health-focused clinical and translational research: Leadership and Resources and Services sections • CC-CHOC is expected to continue as a leadership committee • Future support for Consortium activities is anticipated 3

  4. Therapeutic Repurposing Program (Pilot) PAR-12-203 Pre-application for the NIH-Industry Pilot Program: Discovering New Therapeutic Uses for Existing Molecules (X02) http://grants.nih.gov/grants/guide/pa-files/PAR-12-203.html Released June 12, 2012 NCATS Contacts: Christine Colvis, PhD, ccolvis@mail.nih.gov Heng Xiu, MD, PhD (FAQs) xiuhe@mail.nih.gov Therapeutics.Discovery@nih.gov mailbox 4

  5. Therapeutic Repurposing Program(2) • Pilot: $20 M in FY2013 (Cooperative Agreement) • Phase I: Pre-application (X02) • Based on limited information about the compounds, applicants must propose new therapeutic uses • Explore specific hypotheses to relate one of the compounds to a specific disease • Letter of Intent due July 14 • Applications due August 14 • Phase II: Application (UH2/UH3) by invitation 5

  6. 58 Pharmaceutical Compounds • Companies: AstraZeneca, Eli Lilly, Pfizer, Abbott, BMS, Glaxo, Johnson & Johnson, Sanofi, Janssen • Compounds have already undergone extensive testing including animal tox and early phase human trials; most were shelved because of lack of efficacy • Nominal Indications: Arthritis-9, Pain-9, COPD-7, T2DM-6, Asthma-Schizophrenia-Depression-Malignancy 5 each, Anxiety 4, Allergic Rhinitis 3, Alzheimer-GERD 2 each • http://www.ncats.nih.gov/research/reengineering/rescue-repurpose/therapeutic-uses/directory.html 6

  7. Examples from Table

  8. Other NCATS Announcements • University of Miami received a Clinical and Translational Science Award (CTSA) http://www.ncats.nih.gov/research/cts/ctsa/about/institutions/2012.html • Tissue Chip for Drug Screening program announced 17 awards http://www.ncats.nih.gov/research/reengineering/tissue-chip/tissue-chip.html Other NCATS Funding Opportunities • NIH Support for Conferences and Scientific Meetings (Parent R13/U13)• PA-12-212 • Opportunity to Submit Proposals for the Therapeutics for Rare and Neglected Diseases (TRND) Program• NOT-TR-12-007 • Still no news on permanent director for NCATS or CTSA program 8

More Related